Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
FDA grants premarket approval to Recell for burn treatments
The FDA granted premarket approval to Recell, a spray-on-skin agent, to treat burns in patients aged older than 18 years, its manufacturer announced.
Evidence lacking for comparative effectiveness, safety of skin cancer treatments
A review published in Annals of Internal Medicine found that although several treatment methods for basal cell carcinoma, including surgery, external beam radiation and topical creams, appear effective, evidence is too sparse to determine a best option between the interventions.
Log in or Sign up for Free to view tailored content for your specialty!
Infliximab biosimilar 'only moderately' less costly vs. biologic under Medicare Part D
Under Medicare Part D drug benefits, the biosimilar infliximab-dyyb was only 18% less expensive than the infliximab reference product, exceeding $14,000 annually, according to a research letter published in JAMA.
FDA approves Altreno for acne treatment in kids, adults
The FDA has approved a new drug application for Altreno, a topical treatment for acne vulgaris produced by Ortho Dermatologics.
Psoriasis with less than 10% body surface area can still be severe
FORT WORTH, Texas — Patients with psoriasis affecting less than 10% body surface area can be considered severe cases, especially among those with psoriatic arthritis, based on features including location, quality of life and comorbidities, according to a presenter at the Rheumatology Nurses Society Annual Conference.
Psoriasis increases risk for lymphoma, skin cancer
Patients with psoriasis have a small yet significant increased risk for malignancy compared with the general population, according to research presented at the American Academy of Dermatology Summer Sessions conference.
Education, patience key to guide biosimilar-hesitant patients through transition
FORT WORTH, Texas — Although the use of biosimilars is expected to improve patient access to biologics, open communication between providers and patients is essential to reduce skepticism of the newly available medications, according to a presentation at the Rheumatology Nurses Society Annual Conference.
Fast food consumption linked to asthma, eczema
Eating fast foods, particularly hamburgers, three or more times a week correlated to asthma in a dose-response pattern, according to a systematic review recently published in Respirology.
Nearly 20% of patients with psoriasis also have psoriatic arthritis
Almost one in five patients with psoriasis worldwide also had psoriatic arthritis, with congruous results seen across many different statistical subpopulations, according to data recently published in the Journal of the American Academy of Dermatology.
Mediterranean diet may slow psoriasis progression
Patients with severe psoriasis had low adherence to the Mediterranean diet, suggesting that following the diet may slow the advancement of the condition, according to findings published in JAMA Dermatology.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read